Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 66 results found. Search for [ COVID-19 vaccine Sanofi ]

Results 1 to 21 of 66
BusinessToday.In
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax


Joe C Mathew
September 30, 2020
They state that access to means to fight COVID-19 on a global scale requires financial resources, assets, infrastructure, and jurisdictional support and collaboration beyond the capacity or role of each one of them


Reuters
September 30, 2020
GSK is contributing adjuvants, efficacy boosters that play a vital role in many vaccines, in several development alliances for potential future vaccines against the novel coronavirus that has claimed more than a million lives globally


Reuters
September 18, 2020
The decision by one of the U.N. agency's biggest supporters is a big blow to its strategy aimed at uniting governments around the world to fight the coronavirus pandemic together


BusinessToday.In
September 9, 2020
AstraZeneca said in a statement that its COVID-19 vaccine candidate's trials have been halted, not stopped, as it is going to conduct a review of safety data by an independent committee


Reuters
September 5, 2020
J&J's vaccine is one of over a hundred worldwide being developed in response to the coronavirus pandemic, which has infected nearly 26.5 million people and led to some 869,323 deaths


BusinessToday.In
September 5, 2020
A group of pharma companies are reportedly planning to stand together against the release of any coronavirus vaccine till all safety protocols are complete


PTI
September 4, 2020
Cumulative tests for detection of COVID-19 surged to 4,55,09,380 in the country with a record 11,72,179 tests being conducted in a single day on Wednesday, the Union Health ministry said


PB Jayakumar
September 3, 2020
WHO's recommendation is based on three new studies, plus four other earlier trials, all involving a drug from the family of corticosteroids


Reuters
September 3, 2020
Drugmakers and governments around the world are battling to develop treatments against the COVID-19 pandemic that has claimed more than 861,000 lives and crippled economies


BusinessToday.In
September 1, 2020
Coronavirus vaccine update: AstraZeneca is one of the leading contenders in the race to develop coronavirus vaccine


Reuters
September 1, 2020
Canada's two agreements follow separate deals with Pfizer Inc and Moderna Inc announced weeks ago, and are the latest example of countries rushing to secure access to vaccines


Reuters
August 29, 2020
The company is working on two of the more than 150 potential vaccines being developed across the world to tackle the COVID-19 pandemic


BusinessToday.In
August 29, 2020
COVID-19 vaccine update: The expert group of the committee, headed by Dr. VK Paul, is also in contact with domestic as well as multinational vaccine makers to understand how soon a COVID-19 vaccine will be ready


PB Jayakumar
August 14, 2020
The Western world and the big pharma are upset. They say Russia has not done adequate safety and efficacy studies and the claim is based on testing on less than 100 human volunteers


Reuters
August 12, 2020
Moderna's vaccine candidate, mRNA-1273, is one of the few that have already advanced to the final stage of testing and is on track to be completed in September


BusinessToday.In
August 12, 2020
India Stock Market Highlights Today: Bajaj Finance, followed by L&T, Bajaj Finserv, Sun Pharma, Kotak Bank, HDFC Bank and Reliance Industries were among the top losers on Sensex. On the other hand, SBI, M&M, Maruti, Bajaj Auto and Titan were among the gainers


Reuters
August 7, 2020
The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or around $14.50 per dose, including a previous $456 million the U.S. government promised to J&J for vaccine development in March


Chitranjan Kumar
August 5, 2020
Share market updates and analysis for August 6: RBI policy announcement, earnings announcements and global cues to set tone for stock markets


PB Jayakumar
August 5, 2020
The vaccine, using the platform of plasmid DNA, was found to be safe and well tolerated in the Phase I, which began on 15 July, said Zydus Cadila


PAGES 1 OF 4  1234